ID   LCSC-1
AC   CVCL_5U55
DR   Wikidata; Q54902349
RX   CelloPub=CLPUB00282;
RX   PubMed=19446912;
CC   Doubling time: 18 hours (CelloPub=CLPUB00282).
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
RX   PubMed=19446912; DOI=10.1016/j.jhep.2009.02.022; PMCID=PMC2694236;
RA   Piscaglia, Anna C.
RA   Shupe, Thomas D.
RA   Pani, Giovanbattista
RA   Tesori, Valentina
RA   Gasbarrini, Antonio
RA   Petersen, Bryon E.
RT   "Establishment of cancer cell lines from rat hepatocholangiocarcinoma
RT   and assessment of the role of granulocyte-colony stimulating factor
RT   and hepatocyte growth factor in their growth, motility and survival.";
RL   J. Hepatol. 51:77-92(2009).
//
RX   CelloPub=CLPUB00282;
RA   Piscaglia, Anna C.
RA   Shupe, Thomas D.
RA   Oh, Seh-Hoon
RA   Elyar, John
RA   Gasbarrini, Antonio
RA   Petersen, Bryon E.
RT   "Establishment of a cancer cell line from a model of combined
RT   hepatocholangiocarcinoma (CHCC) in rats.";
RL   Cancer Res. 67 Suppl. 9:1302-1302(2007).
//